Hubert Caron
Impact in
-
- Childhood Cancer Survivors' Quality of Life
- Neurology top 10%
- Neuroblastoma Research and Treatments
Papers in
-
- Childhood Cancer Survivors' Quality of Life 11
- Ethics and Legal Issues in Pediatric Healthcare 2
- Oncology 9
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 2
- Co-authors
- Johannes H. M. MerksRaoul C. M. HennekamClara van KarnebeekMathilde C. Cardous-UbbinkFlora E. van LeeuwenLeontien C.M. KremerRichard C. HeinenPiet Bakker
- Journals
- European Journal of Cancer (7 papers)Pediatric Blood & Cancer (2 papers)Cancer (1 paper)Journal of Clinical Virology (1 paper)Journal of Pediatric Hematology/Oncology (1 paper)
- Partner nations
- NetherlandsSwitzerlandFrance
In The Last Decade
Hubert Caron
23 papers receiving 535 citations
Peers
Comparison fields: 5 of 65
- Pediatrics, Perinatology and Child Health 218
- Neurology 97
- Internal Medicine 22
- Oncology 139
- Genetics 54
Countries citing papers authored by Hubert Caron
This map shows the geographic impact of Hubert Caron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hubert Caron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hubert Caron more than expected).
Fields of papers citing papers by Hubert Caron
This network shows the impact of papers produced by Hubert Caron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hubert Caron. The network helps show where Hubert Caron may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hubert Caron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 0 | |
| 3 | 2022 | 9 | |
| 4 | 2021 | 12 | |
| 5 | 2020 | 20 | |
| 6 | 2020 | 8 | |
| 7 | 2019 | 105 | |
| 8 | 2019 | 12 | |
| 9 | 2016 | 11 | |
| 10 | 2016 | 65 | |
| 11 | 2016 | 25 | |
| 12 | 2015 | 17 | |
| 13 | 2010 | 24 | |
| 14 | 2007 | 6 | |
| 15 | 2006 | 65 | |
| 16 | 2003 | 90 | |
| 17 | A National Late Cancer Treatment Effects Registry in the Netherlands: LATER | 2001 | 1 |
| 18 | 2000 | 10 | |
| 19 | 1996 | 3 | |
| 20 | 1992 | 38 |
About Hubert Caron
Hubert Caron is a scholar working on Pediatrics, Perinatology and Child Health, Oncology, Neurology, Genetics and Internal Medicine, having authored 24 papers that have together received 544 indexed citations. Recurring topics across this work include Childhood Cancer Survivors' Quality of Life (11 papers), Acute Lymphoblastic Leukemia research (6 papers), Neuroblastoma Research and Treatments (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), CAR-T cell therapy research (2 papers), Glioma Diagnosis and Treatment (2 papers), Ethics and Legal Issues in Pediatric Healthcare (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Pediatrics, Perinatology and Child Health (218 citations), Neurology (97 citations), Internal Medicine (22 citations), Oncology (139 citations) and Genetics (54 citations). Hubert Caron has collaborated with scholars based in Netherlands, Switzerland and France. Frequent co-authors include Johannes H. M. Merks, Raoul C. M. Hennekam, Clara van Karnebeek, Mathilde C. Cardous-Ubbink, Flora E. van Leeuwen, Leontien C.M. Kremer, Richard C. Heinen, Piet Bakker, P.A. Voûte and N. G. G. M. Abeling. Their work appears in journals such as European Journal of Cancer, Pediatric Blood & Cancer, Cancer, Journal of Clinical Virology and Journal of Pediatric Hematology/Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.